Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cortexyme Inc (CRTX)

Cortexyme Inc (CRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,672,017
  • Shares Outstanding, K 29,588
  • Annual Sales, $ 0 K
  • Annual Income, $ -76,850 K
  • 60-Month Beta 0.76
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 10.59
Trade CRTX with:

Options Overview

Details
  • Implied Volatility 80.41%
  • Historical Volatility 74.52%
  • IV Percentile 9%
  • IV Rank 12.36%
  • IV High 242.04% on 11/04/20
  • IV Low 57.61% on 07/08/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 357
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 15,838
  • Open Int (30-Day) 16,542

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.70
  • Number of Estimates 3
  • High Estimate -0.42
  • Low Estimate -0.89
  • Prior Year -0.60
  • Growth Rate Est. (year over year) -16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.14 +12.47%
on 07/15/21
66.13 -14.73%
on 07/23/21
+1.24 (+2.25%)
since 07/02/21
3-Month
33.17 +70.00%
on 05/11/21
66.13 -14.73%
on 07/23/21
+17.69 (+45.71%)
since 05/03/21
52-Week
26.66 +111.51%
on 12/29/20
66.13 -14.73%
on 07/23/21
+15.34 (+37.37%)
since 08/03/20

Most Recent Stories

More News
Cortexyme Presents Data Linking P. Gingivalis to Elevated Levels of Phospho-tau217 Reinforcing Evidence of Pathogen as Causative Agent of Alzheimer's Disease at AAIC 2021

--Cortexyme to host AAIC symposium titled "Getting to the Root Cause of Alzheimer's Disease: An Innovative, Upstream Approach for Disease Modification" on Tuesday, July 27

CRTX : 56.19 (-1.77%)
Cortexyme Announces Lead 3CLpro Inhibitor for the Treatment of Coronavirus Infection

Cortexyme, Inc. (Nasdaq: CRTX), a company advancing a pivotal trial in Alzheimer's disease with top-line data expected in the fourth quarter of 2021 and a growing pipeline of therapeutics for degenerative...

CRTX : 56.19 (-1.77%)
Cortexyme to Present New Data at AAIC 2021

Cortexyme, Inc. (Nasdaq: CRTX), a company advancing a pivotal trial in Alzheimer's disease with top-line data expected in the fourth quarter of 2021 and a growing pipeline of therapeutics for degenerative...

CRTX : 56.19 (-1.77%)
Cortexyme Presents New Data Demonstrating Atuzaginstat Disrupts Biofilms and is Efficacious in Preclinical Models of Periodontal Disease at IADR 2021

--Atuzaginstat reverses alveolar bone loss in mice after oral P. gingivalis infection at doses relevant for therapeutic efficacy in periodontal disease

CRTX : 56.19 (-1.77%)
Cortexyme to Host Symposium at AAIC 2021

Cortexyme, Inc. (Nasdaq: CRTX), a company advancing a pivotal trial in Alzheimer's disease with top-line data expected in the fourth quarter of 2021 and a growing pipeline of therapeutics for degenerative...

CRTX : 56.19 (-1.77%)
Noteworthy Wednesday Option Activity: CRTX, TWTR, ETSY

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cortexyme Inc , where a total volume of 2,086 contracts has been traded thus far today,...

CRTX : 56.19 (-1.77%)
Cortexyme to Host Two-Part Key Opinion Leader Webinar Series on Atuzaginstat

--Part 2 to be held Friday July 30 at 10:00 a.m. ET: Innovation in Alzheimer's Disease - Getting to the Root Cause of Neurodegeneration

CRTX : 56.19 (-1.77%)
Cortexyme Presents Updated Baseline Data from Complete Set of Participants Enrolled in Pivotal GAIN Trial at ASCP 2021 Annual Meeting

Cortexyme, Inc. (Nasdaq: CRTX), a company advancing a pivotal trial in Alzheimer's disease with topline data expected in the fourth quarter of 2021 and a growing pipeline of therapeutics for degenerative...

CRTX : 56.19 (-1.77%)
Cortexyme to Present at Investor Conferences in June 2021

Cortexyme, Inc. (Nasdaq: CRTX), a company advancing a pivotal trial in Alzheimer's disease with topline data expected in the fourth quarter of 2021 and a growing pipeline of therapeutics for degenerative...

CRTX : 56.19 (-1.77%)
Cortexyme Provides Business Update and Reports First Quarter 2021 Results

--Top-line data from 233-subject periodontal disease Phase 2 REPAIR sub-study of the

CRTX : 56.19 (-1.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cortexyme Inc. is a clinical-stage biopharmaceutical company. It is focused on providing disease-modifying therapeutics to treat Alzheimer's and other degenerative diseases. The company's drug candidate consists of COR388 which is in clinical stage. Cortexyme Inc. is based in San Francisco, United States....

See More

Key Turning Points

3rd Resistance Point 62.18
2nd Resistance Point 60.43
1st Resistance Point 58.81
Last Price 56.19
1st Support Level 55.44
2nd Support Level 53.69
3rd Support Level 52.07

See More

52-Week High 66.13
Last Price 56.19
Fibonacci 61.8% 51.05
Fibonacci 50% 46.40
Fibonacci 38.2% 41.74
52-Week Low 26.66

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar